Reconsidering T component of cancer staging for T3/T4 non-small-cell lung cancer with additional nodule.
Fang WangHang SuHaoran ELikun HouMinglei YangLong XuJiani GaoMengmeng ZhaoJunqi WuJiajun DengXiaofeng XieYifan ZhongYingze LiTingting WangChunyan WuDong XieChang ChenPublished in: Therapeutic advances in medical oncology (2022)
NSCLC patients with additional nodule(s) in the same lobe and ipsilateral different lobe (maximum tumor diameter ⩽ 3 cm) should be further validated and considered restaging as T2b and T3 in the forthcoming 9th tumor, node, and metastasis staging system.